450 related articles for article (PubMed ID: 26919555)
1. Trends in analgesic exposures reported to Texas Poison Centers following increased regulation of hydrocodone.
Haynes A; Kleinschmidt K; Forrester MB; Young A
Clin Toxicol (Phila); 2016 Jun; 54(5):434-40. PubMed ID: 26919555
[TBL] [Abstract][Full Text] [Related]
2. Trends in hydrocodone combination product exposures reported to California Poison Control System (CPCS) following DEA rescheduling.
Wu A; Phan C; Nguyen KC; Quindoy M; Lewis J; Apollonio DE
Clin Toxicol (Phila); 2021 Apr; 59(4):313-319. PubMed ID: 32840386
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Unintentional Exposures to Codeine and Hydrocodone Reported to Texas Poison Centers.
Day L; Kleinschmidt K; Forrester MB; Feng SY
J Emerg Med; 2016 May; 50(5):744-52. PubMed ID: 26899518
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of opioid prescribing after rescheduling of hydrocodone-containing products.
Bernhardt MB; Taylor RS; Hagan JL; Patel N; Chumpitazi CE; Fox KA; Glover C
Am J Health Syst Pharm; 2017 Dec; 74(24):2046-2053. PubMed ID: 29222361
[TBL] [Abstract][Full Text] [Related]
5. Changes in Hydrocodone Misuse Exposures Reported to U.S. Poison Centers Following Rescheduling in 2014.
Fischer LJ; Severtson SG; Gurrola MC; Iwanicki JL; Green JL; Dart RC
Subst Use Misuse; 2022; 57(7):1097-1103. PubMed ID: 35450512
[TBL] [Abstract][Full Text] [Related]
6. Analgesic utilization before and after rescheduling of hydrocodone in a large academic level 1 trauma center.
Schultz S; Chamberlain C; Vulcan M; Rana H; Patel B; Alexander JC
J Opioid Manag; 2016; 12(2):119-22. PubMed ID: 27194196
[TBL] [Abstract][Full Text] [Related]
7. The impact of more restrictive hydrocodone rescheduling on unintentional pediatric opioid exposures.
Mallama C; Karami S; Zhang D; Zhao Y; Yang Y; Woods C; Ding Y; Meyer T; McAninch J
Pharmacoepidemiol Drug Saf; 2024 Jun; 33(6):e5793. PubMed ID: 38783553
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Opioids Prescribed for Patients at Risk for Opioid Misuse Before and After Publication of the Centers for Disease Control and Prevention's Opioid Prescribing Guidelines.
Scherrer JF; Tucker J; Salas J; Zhang Z; Grucza R
JAMA Netw Open; 2020 Dec; 3(12):e2027481. PubMed ID: 33263762
[TBL] [Abstract][Full Text] [Related]
9. Impact of Hydrocodone Rescheduling on Dental Prescribing of Opioids.
Yan CH; Hubbard CC; Lee TA; Sharp LK; Evans CT; Calip GS; Rowan SA; McGregor JC; Gellad WF; Suda KJ
JDR Clin Trans Res; 2023 Oct; 8(4):402-412. PubMed ID: 35708454
[TBL] [Abstract][Full Text] [Related]
10. Opioid drug poisonings in Ohio adolescents and young adults, 2002-2014.
Caupp S; Steffan J; Shi J; Wheeler KK; Spiller HA; Casavant MJ; Xiang H
Clin Toxicol (Phila); 2018 Aug; 56(8):765-772. PubMed ID: 29322813
[TBL] [Abstract][Full Text] [Related]
11. Using Pill Identification Calls to Poison Centers as a Marker of Drug Abuse at Three Texas Military Bases.
Ng PC; Maddry JK; Sessions D; Borys DJ; Bebarta VS
South Med J; 2017 Nov; 110(11):722-724. PubMed ID: 29100223
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Increased Hydrocodone Regulation on Opioid Prescribing in an Urban Safety-Net Health Care System.
Northrup TF; Carroll K; Suchting R; Villarreal YR; Zare M; Stotts AL
J Am Board Fam Med; 2019; 32(3):362-374. PubMed ID: 31068400
[TBL] [Abstract][Full Text] [Related]
13. Provider specialty and odds of a new codeine, hydrocodone, oxycodone and tramadol prescription before and after the CDC opioid prescribing guideline publication.
Tucker J; Salas J; Zhang Z; Grucza R; Scherrer JF
Prev Med; 2021 May; 146():106466. PubMed ID: 33636196
[TBL] [Abstract][Full Text] [Related]
14. Trends in intentional abuse or misuse of benzodiazepines and opioid analgesics and the associated mortality reported to poison centers across the United States from 2000 to 2014.
Calcaterra SL; Severtson SG; Bau GE; Margolin ZR; Bucher-Bartelson B; Green JL; Dart RC
Clin Toxicol (Phila); 2018 Nov; 56(11):1107-1114. PubMed ID: 29609498
[TBL] [Abstract][Full Text] [Related]
15. The impact of hydrocodone rescheduling on utilization, abuse, misuse, and overdose deaths.
Karami S; Ajao A; Wong J; Zhang D; Meyer T; Ding Y; Secora A; Major JM; Gill R; Chai GP; Zhao Y; McAninch J
Pharmacoepidemiol Drug Saf; 2023 Jul; 32(7):735-751. PubMed ID: 36779261
[TBL] [Abstract][Full Text] [Related]
16. Drug Enforcement Administration Rescheduling of Hydrocodone Combination Products Is Associated With Changes in Physician Pain Management Prescribing Preferences.
Fleming ML; Driver L; Sansgiry SS; Abughosh SM; Wanat MA; Varisco TJ; Pickard T; Reeve K; Todd KH
J Pain Palliat Care Pharmacother; 2019; 33(1-2):22-31. PubMed ID: 31454279
[TBL] [Abstract][Full Text] [Related]
17. Using poison center exposure calls to predict prescription opioid abuse and misuse-related emergency department visits.
Davis JM; Severtson SG; Bucher-Bartelson B; Dart RC
Pharmacoepidemiol Drug Saf; 2014 Jan; 23(1):18-25. PubMed ID: 24130046
[TBL] [Abstract][Full Text] [Related]
18. Comparative Rates of Mortality and Serious Adverse Effects Among Commonly Prescribed Opioid Analgesics.
Murphy DL; Lebin JA; Severtson SG; Olsen HA; Dasgupta N; Dart RC
Drug Saf; 2018 Aug; 41(8):787-795. PubMed ID: 29582394
[TBL] [Abstract][Full Text] [Related]
19. Active surveillance of abused and misused prescription opioids using poison center data: a pilot study and descriptive comparison.
Hughes AA; Bogdan GM; Dart RC
Clin Toxicol (Phila); 2007; 45(2):144-51. PubMed ID: 17364631
[TBL] [Abstract][Full Text] [Related]
20. Pharmacists' perceptions regarding the impact of hydrocodone rescheduling on prescription volume, workflow management, and patient outcomes.
Varisco TJ; Ogunsanya ME; Barner JC; Fleming ML
J Am Pharm Assoc (2003); 2017; 57(2S):S51-S62. PubMed ID: 28292504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
